Aflac Incorporated (NYSE:AFL) Stock Position Raised by Kwmg LLC

Kwmg LLC raised its stake in Aflac Incorporated (NYSE:AFL) by 4.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 86,975 shares of the financial services provider’s stock after buying an additional 3,374 shares during the quarter. Kwmg LLC’s holdings in Aflac were worth $6,071,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Envestnet Asset Management Inc. increased its stake in shares of Aflac by 338.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 5,604,901 shares of the financial services provider’s stock worth $93,656,000 after purchasing an additional 4,325,212 shares during the last quarter. First Trust Advisors LP increased its stake in shares of Aflac by 71.2% during the 1st quarter. First Trust Advisors LP now owns 6,512,084 shares of the financial services provider’s stock worth $420,160,000 after purchasing an additional 2,707,608 shares during the last quarter. Norges Bank acquired a new position in shares of Aflac during the 4th quarter worth $175,416,000. Invesco Ltd. increased its stake in shares of Aflac by 62.4% during the 1st quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock worth $317,865,000 after purchasing an additional 1,897,212 shares during the last quarter. Finally, Morgan Stanley increased its stake in shares of Aflac by 22.9% during the 4th quarter. Morgan Stanley now owns 8,812,956 shares of the financial services provider’s stock worth $634,004,000 after purchasing an additional 1,640,984 shares during the last quarter. Institutional investors and hedge funds own 66.75% of the company’s stock.

Aflac Price Performance

Shares of NYSE:AFL traded down $0.80 during midday trading on Friday, reaching $76.51. 5,220,708 shares of the company’s stock were exchanged, compared to its average volume of 2,444,733. The company’s 50 day simple moving average is $73.94 and its two-hundred day simple moving average is $69.04. The firm has a market capitalization of $45.45 billion, a PE ratio of 10.23, a price-to-earnings-growth ratio of 2.33 and a beta of 0.93. Aflac Incorporated has a 12 month low of $56.03 and a 12 month high of $78.43. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.07 and a current ratio of 0.07.

Aflac (NYSE:AFL) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.16. The company had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.52 billion. Aflac had a net margin of 24.48% and a return on equity of 16.10%. Equities research analysts expect that Aflac Incorporated will post 5.98 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 1st. Investors of record on Wednesday, August 23rd were given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date of this dividend was Tuesday, August 22nd. Aflac’s dividend payout ratio (DPR) is currently 22.46%.

Wall Street Analyst Weigh In

AFL has been the topic of several analyst reports. Jefferies Financial Group increased their price target on shares of Aflac from $70.00 to $74.00 and gave the stock a “hold” rating in a research note on Thursday. 888 reiterated a “reiterates” rating on shares of Aflac in a research note on Friday, June 9th. Citigroup raised their target price on shares of Aflac from $69.00 to $76.00 and gave the company a “neutral” rating in a research note on Wednesday, August 9th. StockNews.com started coverage on shares of Aflac in a research note on Thursday, August 17th. They issued a “hold” rating on the stock. Finally, Wells Fargo & Company increased their price target on shares of Aflac from $71.00 to $78.00 and gave the company an “equal weight” rating in a report on Tuesday, August 15th. Eight research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus price target of $75.82.

Insider Buying and Selling

In related news, Director Joseph L. Moskowitz sold 500 shares of the stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $69.60, for a total transaction of $34,800.00. Following the completion of the sale, the director now owns 27,085 shares in the company, valued at approximately $1,885,116. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Virgil Raynard Miller sold 2,626 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $77.08, for a total transaction of $202,412.08. Following the completion of the sale, the insider now owns 2,181 shares in the company, valued at approximately $168,111.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Joseph L. Moskowitz sold 500 shares of the firm’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $69.60, for a total transaction of $34,800.00. Following the completion of the sale, the director now owns 27,085 shares of the company’s stock, valued at approximately $1,885,116. The disclosure for this sale can be found here. Insiders sold 30,170 shares of company stock worth $2,286,000 in the last quarter. 0.90% of the stock is owned by corporate insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.